In STAT Interview, Unitaid Interim Executive Director Discusses Organization’s Efforts To Address COVID-19 Pandemic, Importance Of Access To Medical Products

STAT: Poor countries must not be forgotten in the Covid-19 battle, Unitaid director warns
“Founded more than a dozen years ago, Unitaid has received more than $3 billion in donations for its work to research and identify solutions to such tenacious diseases as HIV/AIDS, tuberculosis, and malaria. … Unitaid recently endorsed the idea of having the WHO create a voluntary pool to collect intellectual property, which would gather patents, regulatory test data, and other information to ensure ‘equitable access’ to vaccines, treatments, and other medical products for combating Covid-19. We spoke with Philippe Duneton, the interim executive director, about Unitaid efforts to combat the pandemic and why widening access to medical products must be a global priority…” (Silverman, 4/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.